Lamivudine monotherapy-based cART is efficacious for HBV treatment in HIV/HBV co-infection when baseline HBV DNA<20,000IU/ml

BACKGROUND: Although combination antiretroviral therapy (cART) including tenofovir (TDF)+lamivudine (3TC) or emtricitabine (FTC) is recommended for treatment of HIV/HBV co-infected patients, TDF is unavailable in some resource-limited areas. Some data suggest that 3TC monotherapy-based cART may be e...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Acquir Immune Defic Syndr
Asıl Yazarlar: LI, Yijia, XIE, Jing, HAN, Yang, WANG, Huanling, ZHU, Ting, WANG, Nidan, LV, Wei, GUO, Fuping, QIU, Zhifeng, LI, Yanling, DU, Shanshan, SONG, Xiaojing, THIO, Chloe L, LI, Taisheng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4977191/
https://ncbi.nlm.nih.gov/pubmed/26745828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000927
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller